To include your compound in the COVID-19 Resource Center, submit it here.

BBR 3464: Began Phase II trial

Novuspharma S.p.A. (NMerct:NOV), Milan, Italy
Product: BBR 3464

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE